MedPath

Simulator Training to Improve Interventional Cardiologist Skills (STARTERS) Trial

Not Applicable
Not yet recruiting
Conditions
Coronary Artery Disease
Registration Number
NCT06358105
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

The goal of this clinical trial is to learn if simulator-based training will improve interventional cardiology fellows' skills and will improve patient outcomes.

The main questions it aims to answer are:

* Does this training improve specific operative parameters recorded during initial coronary interventions performed as first operators under senior supervision?

* Will major and minor procedural complications be reduced after simulator-based training?

Interventional cardiology fellows in their first year of training will be randomized between standard master-apprentice training or simulator-based training before starting their cath lab period.

They will be supervised during their cath lab period as first operators by senior interventional cardiologists.

During their first 50 procedures performed as supervised first operator, specific procedural data will be collected.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Specializing doctors who are about to start dedicated training in the interventional cardiology room
  • Patients who must undergo coronary angiography examination.
Exclusion Criteria

Specializing doctors:

  • No interest in performing interventional cardiology procedures as first supervised operator (classical training)
  • Experience as first supervised operator in interventional cardiology procedures
  • Absence of informed consent

Patients:

  • Acute Coronary Syndrome
  • Severe left ventricular dysfunction with ejection fraction less than 30%
  • Severe chronic renal failure (with glomerular filtration rate less than 30 ml/min)
  • Absence of informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Mean total fluoroscopy radiation time (expressed in seconds)End of procedure

Difference in Mean total fluoroscopy radiation time, during the periods where the cardiology fellows act as primary operators, between groups

Secondary Outcome Measures
NameTimeMethod
Total radiation dose (expressed in cGy*cm2)End of procedure

Difference in total radiation dose adsorbed by patients as evaluated by dose-area product (DAP) (expressed in Gycm2)

Number of catheters usedEnd of procedure

Difference in number of catheters used to complete the diagnostic procedure

Any major or minor procedural and clinical complicationUp to the end of index hospitalization or date of death from any cause (we collect any kind of clinical or procedural complication occuring during the determined period)

Difference in any major or minor complication occurred during the procedure or the index hospitalization

Total contrast dose (expressed in ml)End of procedure

Difference in total contrast dose administered to the patients

Failure to achieve arterial cannulation (e.g.: rate of failure for each partecipant)End of procedure

Difference in failure to achieve arterial cannulation

Mean arterial cannulation time (expressed in seconds)End of procedure

Difference in mean coronary cannulation time is considered as the time from sheath insertion to first right and left selective coronary angiography obtained (expressed in minutes)

Failure to achieve left coronary cannulation (e.g.: rate of failure for each partecipant)End of procedure

Difference in failure to achieve left coronary cannulation

Failure to achieve right coronary cannulation (e.g.: rate of failure for each partecipant)End of procedure

Difference in failure to achieve right coronary cannulation

Trial Locations

Locations (1)

Fondazione Policlinico Univrsitario Agostino Gemelli IRCCS

🇮🇹

Rome, Italy

Fondazione Policlinico Univrsitario Agostino Gemelli IRCCS
🇮🇹Rome, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.